Aethlon Medical Inc.
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Website
- aethlonmedical.com
- Founded
- 1999
- Employees
- 11-50
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | -$4 |
Contract awards
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| The hemopurifier device for targeted removal of breast cancer exosomes from the blood circulation | National Cancer Institute (NIH) | $298,444 |
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| University Of Pittsburgh - Of The Commonwealth System Of Higher Education | U01DE029759 | -$47,350 | |
| University Of Pittsburgh - Of The Commonwealth System Of Higher Education | U01DE029759 | $47,350 | |
| University Of Pittsburgh - Of The Commonwealth System Of Higher Education | U01DE029759 | $47,350 |
Similar vendors
About the company
Here is a detailed, three paragraph summary on Aethlon Medical Inc. - doing business as Aethlon:
Aethlon Medical Inc. is a medical device company that creates devices for cancer, infectious disease, and other life-threatening conditions. Their ADAPTTM platform provides the technology foundation for a new class of therapeutics.
Through a prime federal contract with the Department of Health and Human Services National Institutes of Health National Cancer Institute, Aethlon Medical Inc. provided research and development services related to a device prototype for isolating melanoma exosomes for diagnostics and treatment monitoring. This $1.86 million definitive contract set aside for small businesses was awarded in September 2019 with a completion date of September 2022.
Aethlon Medical Inc. has not directly received any prime federal grants but has participated as a sub awardee on federal grants for research related to depleting exosomes to improve responses to immune therapy in head and neck squamous cell carcinoma. The prime grantee for these sub awards was the University of Pittsburgh.
SBA capabilities narrative
Aethlon Medical is developing new therapies for cricial unmet needs in viral diseases and cancer. One focus is on viral bioweapons which are or may be both drug and vaccine resistant. A second focus is on chronic, drug resistant viral conditions.
Quick answers
Is Aethlon Medical Inc. registered in SAM.gov?
Aethlon Medical Inc.'s SAM.gov registration was deleted on August 18, 2016.
What is Aethlon Medical Inc.'s CAGE code?
Aethlon Medical Inc.'s CAGE code is 47A31, and its Unique Entity ID (UEI) is MUNVGHPLRV56.
What is Aethlon Medical Inc.'s most recent federal award?
Aethlon Medical Inc.'s most recent federal contract award is Topic 359: a device prototype for isolation of melanoma exosomes for diagnostics and treatment monitoring (75N91019C00042), from National Cancer Institute (NIH), on September 16, 2019.
On GovTribe
See Aethlon Medical Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors